USFDA issue EIR to Lupin; stock shines on the bourses USFDA issue EIR to Lupin; stock shines on the bourses Amir Shaikh / Monday, April 13, 2020 / Article rating: 3.8 Pharma major Lupin informed the bourses today that it has received an establishment inspection report (EIR) after closure of USFDA inspection of its Nagpur (India) facility
IDBI Bank advances on bourses post fund raising plan IDBI Bank advances on bourses post fund raising plan Amir Shaikh / Thursday, April 9, 2020 / Article rating: 3.7 IDBI Bank on Wednesday informed the bourses that its board of directors has approved rupee bond borrowing limit of Rs 7,500 crore for FY 2020-21 to be borrowed in one or more tranches
Gujarat Alkalies resume partial production; hit upper circuit Gujarat Alkalies resume partial production; hit upper circuit Amir Shaikh / Wednesday, April 8, 2020 / Article rating: 3.9 Gujarat Alkalies & Chemicals (GACL) on Tuesday informed the bourses that it has started partial operation of poly aluminium chloride (PAC) and hydrogen peroxide plants at Dahej complex and chloromethane & poly aluminium chloride (PAC) plants at Vadodara
Zydus Cadila receives USFDA approval for Perphenazine Zydus Cadila receives USFDA approval for Perphenazine Amir Shaikh / Tuesday, April 7, 2020 / Article rating: 3.8 Zydus Cadila has received a final approval from US Food & Drug Administration (USFDA) to market Perphenazine tablets USP, 2 mg, 4 mg, 8 mg and 16 mg (US RLD: Trilafon tablets)
Cement demand likely to contract 20-25 per cent: CRISIL Cement demand likely to contract 20-25 per cent: CRISIL Amir Shaikh / Tuesday, April 7, 2020 / Article rating: 2.5 Ratings agency CRISIL in its latest report stated that cement demand in India is expected to dip by nearly 20 to 25 per cent in the current fiscal year if the country is unable to contain the pandemic by the month of May
Jubilant Life Sciences surge on receiving EIR Jubilant Life Sciences surge on receiving EIR Amir Shaikh / Wednesday, April 1, 2020 / Article rating: 3.0 Jubilant Life Sciences informed the bourses on Tuesday that its subsidiary, Jubilant Pharma, through one of its wholly-owned subsidiaries, has received an establishment inspection report
Supreme Court allows selling of only 10 per cent BS4 inventory Supreme Court allows selling of only 10 per cent BS4 inventory Amir Shaikh / Monday, March 30, 2020 / Article rating: 4.0 Supreme Court (SC) on Friday gave some relief to the auto industry for selling Bharat Stage 4 (BS4) inventory within 10 days amidst the current lockdown
Moodys downgrades credit rating of Motherson Sumi Systems Moodys downgrades credit rating of Motherson Sumi Systems Amir Shaikh / Monday, March 30, 2020 / Article rating: 4.0 Motherson Sumi Systems on Saturday informed the bourses that the rating agency Moody’s Corporation has assigned Ba1 corporate family rating (CFR) to the flagship company of Motherson Group
COVID-19: Maruti Suzuki to produce ventilators & masks COVID-19: Maruti Suzuki to produce ventilators & masks Amir Shaikh / Monday, March 30, 2020 / Article rating: 3.0 Maruti Suzuki India has informed the bourses that it has examined its ability to assist in the production of ventilators, masks and other protective equipments
CRISIL cuts India growth forecast CRISIL cuts India growth forecast Amir Shaikh / Friday, March 27, 2020 / Article rating: 3.0 Rating agency-CRISIL has cut its growth estimate for India to 3.5 per cent for the next financial year (FY21) amid severe dent in the economic activity due to COVID-19 pandemic